These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 14632300)
1. Radiation bronchitis in lung cancer patient treated with stereotactic radiation therapy. Uno T; Aruga T; Isobe K; Motori K; Kawakami H; Ueno N; Ito H Radiat Med; 2003; 21(5):228-31. PubMed ID: 14632300 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Onishi H; Kuriyama K; Komiyama T; Tanaka S; Sano N; Marino K; Ikenaga S; Araki T; Uematsu M Lung Cancer; 2004 Jul; 45(1):45-55. PubMed ID: 15196734 [TBL] [Abstract][Full Text] [Related]
3. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260 [TBL] [Abstract][Full Text] [Related]
4. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Zimmermann FB; Geinitz H; Schill S; Grosu A; Schratzenstaller U; Molls M; Jeremic B Lung Cancer; 2005 Apr; 48(1):107-14. PubMed ID: 15777977 [TBL] [Abstract][Full Text] [Related]
5. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949 [TBL] [Abstract][Full Text] [Related]
6. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670 [TBL] [Abstract][Full Text] [Related]
8. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Thirion P; Holmberg O; Collins CD; O'Shea C; Moriarty M; Pomeroy M; O'Sullivan C; Buckney S; Armstrong J Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449 [TBL] [Abstract][Full Text] [Related]
10. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346 [TBL] [Abstract][Full Text] [Related]
11. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Hara R; Itami J; Kondo T; Aruga T; Uno T; Sasano N; Ohnishi K; Kiyozuka M; Fuse M; Ito M; Naoi K; Kohno Y Cancer; 2006 Mar; 106(6):1347-52. PubMed ID: 16475150 [TBL] [Abstract][Full Text] [Related]
13. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428 [TBL] [Abstract][Full Text] [Related]
14. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000 [TBL] [Abstract][Full Text] [Related]
15. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer. Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134 [TBL] [Abstract][Full Text] [Related]
16. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503 [TBL] [Abstract][Full Text] [Related]
18. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. Kyas I; Hof H; Debus J; Schlegel W; Karger CP Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):768-74. PubMed ID: 17097829 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Hiraoka M; Matsuo Y; Nagata Y Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]